Shaping Gene Expression in Activated and Resting Primary Macrophages by IL-101
暂无分享,去创建一个
Peter J. Murray | Roland Lang | D. Patel | P. Murray | J. J. Morris | R. Lang | Robert L. Rutschman | Divyen Patel | John J. Morris
[1] A. Brasier,et al. NF-κB-inducible BCL-3 Expression Is an Autoregulatory Loop Controlling Nuclear p50/NF-κB1 Residence* , 2001, The Journal of Biological Chemistry.
[2] H. Pendeville,et al. SOCS3 Is Essential in the Regulation of Fetal Liver Erythropoiesis , 1999, Cell.
[3] K Eichmann,et al. Th1/Th2-regulated expression of arginase isoforms in murine macrophages and dendritic cells. , 1999, Journal of immunology.
[4] R. Coffman,et al. Interleukin-10 and the interleukin-10 receptor. , 2001, Annual review of immunology.
[5] M. Munder,et al. Alternative metabolic states in murine macrophages reflected by the nitric oxide synthase/arginase balance: competitive regulation by CD4+ T cells correlates with Th1/Th2 phenotype. , 1998, Journal of immunology.
[6] D. Pappin,et al. Activation of MEK‐1 and SEK‐1 by Tpl‐2 proto‐oncoprotein, a novel MAP kinase kinase kinase. , 1996, The EMBO journal.
[7] J. G. Zhang,et al. Suppressor of cytokine signaling-3 preferentially binds to the SHP-2-binding site on the shared cytokine receptor subunit gp130. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[8] Wei Zhang,et al. Molecular cloning and characterization of NF-IL3A, a transcriptional activator of the human interleukin-3 promoter , 1995, Molecular and cellular biology.
[9] H. Dickensheets,et al. The interleukin-10 signal transduction pathway and regulation of gene expression in mononuclear phagocytes. , 1999, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[10] P. Heinrich,et al. SOCS3 Exerts Its Inhibitory Function on Interleukin-6 Signal Transduction through the SHP2 Recruitment Site of gp130* , 2000, The Journal of Biological Chemistry.
[11] Ash A. Alizadeh,et al. Stereotyped and specific gene expression programs in human innate immune responses to bacteria , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[12] H. Hurst,et al. Transcriptional repression by a novel member of the bZIP family of transcription factors , 1992, Molecular and cellular biology.
[13] H. Dickensheets,et al. Interleukin-10 Inhibits Expression of Both Interferon – and Interferon γ– Induced Genes by Suppressing Tyrosine Phosphorylation of STAT1 , 1999 .
[14] Y. Vodovotz,et al. Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-beta and interleukin-10. , 1992, The Journal of biological chemistry.
[15] R. Schreiber,et al. Disruption of the Jak1 Gene Demonstrates Obligatory and Nonredundant Roles of the Jaks in Cytokine-Induced Biologic Responses , 1998, Cell.
[16] E. Lander,et al. Human macrophage activation programs induced by bacterial pathogens , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[17] R. Flavell,et al. GADD45gamma mediates the activation of the p38 and JNK MAP kinase pathways and cytokine production in effector TH1 cells. , 2001, Immunity.
[18] Y. Liu,et al. IL‐10 inhibits macrophage activation and proliferation by distinct signaling mechanisms: evidence for Stat3‐dependent and ‐independent pathways , 1998, The EMBO journal.
[19] G. Trinchieri,et al. Molecular mechanisms of the induction of IL-12 and its inhibition by IL-10. , 1998, Journal of immunology.
[20] M. Modolell,et al. Reciprocal regulation of the nitric oxide synthase/arginase balance in mouse bone marrow‐derived macrophages by TH 1 and TH 2 cytokines , 1995, European journal of immunology.
[21] M. Mayo,et al. Interleukin-10 Signaling Blocks Inhibitor of κB Kinase Activity and Nuclear Factor κB DNA Binding* , 1999, The Journal of Biological Chemistry.
[22] T. Gotoh,et al. Regulation of the genes for arginase isoforms and related enzymes in mouse macrophages by lipopolysaccharide. , 1999, American journal of physiology. Endocrinology and metabolism.
[23] P. Rutgeerts,et al. Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease , 2000 .
[24] S. Akira,et al. Interleukin-10 Receptor Signaling through the JAK-STAT Pathway , 1999, The Journal of Biological Chemistry.
[25] W. Greene,et al. The Proto-Oncogene Cot Kinase Participates in CD3/CD28 Induction of NF-κB Acting through the NF-κB-Inducing Kinase and IκB Kinases , 1999 .
[26] George Kollias,et al. Interleukin‐10 targets p38 MAPK to modulate ARE‐dependent TNF mRNA translation and limit intestinal pathology , 2001, The EMBO journal.
[27] P. Rutgeerts,et al. Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease. The Interleukin 10 Inflammatory Bowel Disease Cooperative Study Group. , 2000, Gastroenterology.
[28] T. Gingeras,et al. Reprogramming of the macrophage transcriptome in response to interferon-gamma and Mycobacterium tuberculosis: signaling roles of nitric oxide synthase-2 and phagocyte oxidase. , 2001, The Journal of experimental medicine.
[29] P. Pavlidis,et al. Cutting Edge: STAT6 Serves as a Positive and Negative Regulator of Gene Expression in IL-4-Stimulated B Lymphocytes1 , 2002, The Journal of Immunology.
[30] F. Larminat,et al. Overexpression of Metallothionein-II Sensitizes Rodent Cells to Apoptosis Induced by DNA Cross-linking Agent through Inhibition of NF-κB Activation* , 2002, The Journal of Biological Chemistry.
[31] T. van der Poll,et al. Proinflammatory Effects of IL-10 During Human Endotoxemia1 , 2000, The Journal of Immunology.
[32] T. Gingeras,et al. Reprogramming of the Macrophage Transcriptome in Response to Interferon-γ and Mycobacterium tuberculosis , 2001, The Journal of experimental medicine.
[33] R. Young,et al. T cell-derived IL-10 antagonizes macrophage function in mycobacterial infection. , 1997, Journal of immunology.
[34] J. Ihle,et al. Cutting Edge: Stat6-Dependent Substrate Depletion Regulates Nitric Oxide Production1 , 2001, The Journal of Immunology.
[35] H. Dickensheets,et al. Interleukin-10 upregulates tumor necrosis factor receptor type-II (p75) gene expression in endotoxin-stimulated human monocytes. , 1997, Blood.
[36] K. Heeg,et al. Suppressors of Cytokine Signaling (SOCS)-1 and SOCS-3 Are Induced by CpG-DNA and Modulate Cytokine Responses in APCs1 , 2001, The Journal of Immunology.
[37] W. Alexander,et al. The SOCS box: a tale of destruction and degradation. , 2002, Trends in biochemical sciences.
[38] S. Akira,et al. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. , 1999, Immunity.
[39] G. Davis,et al. Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: a pilot trial of interferon nonresponders. , 2000, Gastroenterology.
[40] G. Kollias,et al. TNF-α Induction by LPS Is Regulated Posttranscriptionally via a Tpl2/ERK-Dependent Pathway , 2000, Cell.
[41] R. Donnelly,et al. Inhibition of IL-10 expression by IFN-gamma up-regulates transcription of TNF-alpha in human monocytes. , 1995, Journal of immunology.
[42] J. Johnston,et al. Lipopolysaccharide induces in macrophages the synthesis of the suppressor of cytokine signaling 3 and suppresses signal transduction in response to the activating factor IFN-gamma. , 1999, Journal of immunology.
[43] S. Goerdt,et al. Other functions, other genes: alternative activation of antigen-presenting cells. , 1999, Immunity.
[44] P. Heinrich,et al. Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. , 1998, The Biochemical journal.
[45] I. Udalova,et al. Evidence for a Dual Mechanism for IL-10 Suppression of TNF-α Production That Does Not Involve Inhibition of p38 Mitogen-Activated Protein Kinase or NF-κB in Primary Human Macrophages1 , 2002, The Journal of Immunology.
[46] K. Rajewsky,et al. Interleukin-10-deficient mice develop chronic enterocolitis , 1993, Cell.